Personalised Postoperative Radiochemotherapy in Patients With Head and Neck Cancer
NCT ID: NCT02666885
Last Updated: 2019-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
49 participants
INTERVENTIONAL
2015-07-31
2019-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Individualized Response-adaptive Radiation Dose Prescription in HNC Based on MRI
NCT05160714
Prediction of Outcome After Chemoradiotherapy for Head and Neck Cancer Using Functional Imaging and Tumor Biology
NCT01829646
A Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer
NCT00490282
A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer
NCT01208883
Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor
NCT00406289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Integration of PET/MRI in radiotherapy
Integration of pretherapeutical PET/MRI in adjuvant radiotherapy
Integration of PET/MRI in radiotherapy
Integration of pretherapeutical PET/MRI in adjuvant radiotherapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Integration of PET/MRI in radiotherapy
Integration of pretherapeutical PET/MRI in adjuvant radiotherapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no contraindications for PET/MRI
* no contraindications for radiochemotherapy
* informed consent
* ECOG PS 0/2
Exclusion Criteria
* previous PET/CT
* induction therapy
* pregnancy or breastfeeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel Zips, MD, Prof
Role: PRINCIPAL_INVESTIGATOR
University Hospital Tuebingen, Department of Radiation Oncology, Tuebingen, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Tübingen, Department of Radiation Oncology
Tübingen, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZPM_Demonstrator_HNC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.